Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.
about
Human cytomegalovirus: challenges, opportunities and new drug developmentNew strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsCurrent recommendations for the treatment of genital herpes.Lobucavir is phosphorylated in human cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase
P2860
Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Evaluation of SQ 34,514: pharm ...... erpesvirus infections in mice.
@en
type
label
Evaluation of SQ 34,514: pharm ...... erpesvirus infections in mice.
@en
prefLabel
Evaluation of SQ 34,514: pharm ...... erpesvirus infections in mice.
@en
P2093
P2860
P356
P1476
Evaluation of SQ 34,514: pharm ...... erpesvirus infections in mice.
@en
P2093
Braitman A
Michalik T
Swerdel MR
Tuomari AV
P2860
P304
P356
10.1128/AAC.35.7.1464
P407
P577
1991-07-01T00:00:00Z